* TuHURA Biosciences Inc reported a quarterly adjusted loss of $1.37​​ per share for the quarter , higher than the same quarter last year, when the company reported EPS of $-64.05. The lone analyst forecast for the quarter was for a loss of 10 cents per share.

* Reported revenue was zero​; analysts expected zero.

* TuHURA Biosciences Inc's reported EPS for the quarter was a loss of $1.37​.

* The company reported a quarterly loss of $2.18 million.

* TuHURA Biosciences Inc shares had fallen by 28.2% this quarter and lost 17.5% so far this year.

FORECAST CHANGES

* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

* The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for TuHURA Biosciences Inc is $15.00 This summary was machine generated from LSEG data November 15 at 02:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 -0.10 -1.37 Missed